Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2017

2017-03-31
Price :
Published : Mar-2017
No. of Pages : 224

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Anaplastic Astrocytoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Anaplastic Astrocytoma to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Anaplastic Astrocytoma Therapeutics Clinical Trials 34
Prominent Drugs 36
Clinical Trial Profile Snapshots 37
Appendix 277
Abbreviations 277
Definitions 277
Research Methodology 278
Secondary Research 278
About GlobalData 279
Contact Us 279
Disclaimer 279
Source 280

List of Tables

Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials by Region, 2017* 6
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Anaplastic Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Anaplastic Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Anaplastic Astrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Anaplastic Astrocytoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Anaplastic Astrocytoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Anaplastic Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Anaplastic Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Anaplastic Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Anaplastic Astrocytoma to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Anaplastic Astrocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Anaplastic Astrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials by Phase, 2017* 25
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 31
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36

List of Figures

Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Anaplastic Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Anaplastic Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Anaplastic Astrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Anaplastic Astrocytoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Anaplastic Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Anaplastic Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Anaplastic Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Anaplastic Astrocytoma to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Anaplastic Astrocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Anaplastic Astrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26
Anaplastic Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 31
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
GlobalData Methodology 278

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData